| Model Number |
10FCC13 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Aortic dissection (4870)
|
| Date of Event |
09/08/2025
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id: pscc100 product type: catheter product id: non-medtronic product type: guidewire.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during a pulsed field ablation procedure, when the catheter was removed there was tissue adhered to the catheter.The case was completed with pulsed field ablation.No patient complications have been reported as a result of this event.2025-12-19: additional information was received indicating that the guidewire extending from the tip of the pulseselect became caught on the chordae tendineae, resulting in chordal rupture.Subsequently, the patient was transferred to another hospital on the same day, where surgery was performed.The postoperative course was favorable, and rehabilitation progressed well.However, it was later reported that the patient developed aortic dissection and died.
|
| |
|
Event or Problem Description
|
|
It was later reported that both pulsed field ablation and radiofrequency (rf) were used during the procedure.Additionally, the physician stated that the patient died of aortic dissection a few months after the procedure, the incident was not related to medtronic products or procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|